Peptide pretreatment blunts cell-based kidney repair in mice
Groups of six mice received human stromal cells; peptide pretreatment failed to rescue repair by cells from donors with obesity and blunted benefits from donors without obesity.
Our read
Interventions- Studied:
- Experiments in mice with narrowed kidney arteries, against mice receiving untreated lean-donor cells (Randomized, blinded)
- What changed:
- Peptide-pretreated cells from donors without obesity repaired mouse kidneys less effectively than untreated cells
- The catch:
- Only six mice per group were used to assess kidney repair
- In the record:
- The 6th paper on MOTS-c with results in people; 112 on record in all. Its result on AMPK signaling agrees with all 10 other findings on record.
Editor of record: Boris Djordjevic · AgingResearch.News
Researchers tested human mesenchymal stromal cells, which have repair potential, from abdominal fat of six donors with obesity and six without, aged 18–80. They exposed cells to 10 micromolar MOTS-c, a short protein fragment, for 48 hours. In cells from donors with obesity, it activated metabolic signaling but reduced multiplication. It also increased activity of genes linked to inflammation and senescence, a state in which cells stop dividing.
In a randomized animal experiment with six mice per group, researchers injected untreated or pretreated cells into mice with narrowed kidney arteries. Two weeks later, pretreated cells from donors with obesity had not improved kidney blood flow, scarring or damage to tubules, the kidney’s small tubes. Pretreatment also blunted the repair benefits of cells from donors without obesity.
Why it matters
Cell senescence connects this work to questions about maintaining tissue repair with age. The authors suggest that the effects of these protein fragments depend on cellular context.
Caveats
These were experiments in cells grown in the lab and mice, not tests of kidney repair in people. The cells came from only six donors per group.
The paper
Mayo Clinic
Inflammation and Regeneration, Jun 22, 2026, Open access


Comments
Be the first to comment.